Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 6.0
(-0.17%)
CNY 6.0
(-0.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -71.75 Million CNY | -735.92% |
| 2022 | 11.28 Million CNY | -91.01% |
| 2021 | 125.51 Million CNY | -28.15% |
| 2020 | 174.7 Million CNY | -48.98% |
| 2019 | 342.43 Million CNY | 131.75% |
| 2018 | 147.76 Million CNY | 24.36% |
| 2017 | 118.81 Million CNY | 625.4% |
| 2016 | 16.37 Million CNY | -49.72% |
| 2015 | 32.57 Million CNY | -62.45% |
| 2014 | 86.76 Million CNY | 31.52% |
| 2013 | 65.97 Million CNY | 4.65% |
| 2012 | 63.03 Million CNY | 42.58% |
| 2011 | 44.21 Million CNY | 3.36% |
| 2010 | 42.77 Million CNY | 22.69% |
| 2009 | 34.86 Million CNY | 33.81% |
| 2008 | 26.05 Million CNY | -5.84% |
| 2007 | 27.66 Million CNY | 125.1% |
| 2006 | 12.29 Million CNY | 34.48% |
| 2005 | 9.14 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 8.01 Million CNY | -30.46% |
| 2024 Q3 | 4.85 Million CNY | -39.45% |
| 2024 Q1 | 11.52 Million CNY | 115.64% |
| 2023 Q3 | -7.65 Million CNY | -157.51% |
| 2023 Q4 | -73.69 Million CNY | -862.15% |
| 2023 FY | -71.75 Million CNY | -735.92% |
| 2023 Q1 | 12.57 Million CNY | 128.56% |
| 2023 Q2 | -2.97 Million CNY | -123.65% |
| 2022 Q3 | 15.23 Million CNY | 1957.95% |
| 2022 FY | 11.28 Million CNY | -91.01% |
| 2022 Q2 | 740.11 Thousand CNY | -98.12% |
| 2022 Q4 | -44.02 Million CNY | -389.07% |
| 2022 Q1 | 39.26 Million CNY | 926.44% |
| 2021 Q2 | 66.02 Million CNY | 30.87% |
| 2021 Q1 | 50.45 Million CNY | 255.36% |
| 2021 Q4 | -4.75 Million CNY | -135.82% |
| 2021 Q3 | 13.26 Million CNY | -79.91% |
| 2021 FY | 125.51 Million CNY | -28.15% |
| 2020 FY | 174.7 Million CNY | -48.98% |
| 2020 Q2 | 64.77 Million CNY | 141.85% |
| 2020 Q3 | 68.94 Million CNY | 6.42% |
| 2020 Q4 | 14.19 Million CNY | -79.41% |
| 2020 Q1 | 26.78 Million CNY | -84.72% |
| 2019 Q2 | 71.45 Million CNY | 76.15% |
| 2019 FY | 342.43 Million CNY | 131.75% |
| 2019 Q4 | 175.28 Million CNY | 217.94% |
| 2019 Q3 | 55.13 Million CNY | -22.85% |
| 2019 Q1 | 40.56 Million CNY | 89.31% |
| 2018 FY | 147.76 Million CNY | 24.36% |
| 2018 Q3 | 41.64 Million CNY | -25.55% |
| 2018 Q1 | 28.75 Million CNY | 88.12% |
| 2018 Q4 | 21.42 Million CNY | -48.54% |
| 2018 Q2 | 55.93 Million CNY | 94.53% |
| 2017 Q4 | 15.28 Million CNY | -51.58% |
| 2017 FY | 118.81 Million CNY | 625.4% |
| 2017 Q2 | 45.54 Million CNY | 72.39% |
| 2017 Q1 | 26.41 Million CNY | 140.33% |
| 2017 Q3 | 31.57 Million CNY | -30.68% |
| 2016 Q1 | 20.51 Million CNY | 144.72% |
| 2016 Q3 | 24.48 Million CNY | -32.31% |
| 2016 Q2 | 36.18 Million CNY | 76.37% |
| 2016 Q4 | -65.5 Million CNY | -367.48% |
| 2016 FY | 16.37 Million CNY | -49.72% |
| 2015 Q3 | 22.91 Million CNY | -34.7% |
| 2015 FY | 32.57 Million CNY | -62.45% |
| 2015 Q2 | 35.09 Million CNY | 71.79% |
| 2015 Q4 | -45.86 Million CNY | -300.13% |
| 2015 Q1 | 20.43 Million CNY | -21.01% |
| 2014 Q4 | 25.86 Million CNY | 33.24% |
| 2014 Q1 | 15.84 Million CNY | -6.95% |
| 2014 Q2 | 25.64 Million CNY | 61.8% |
| 2014 FY | 86.76 Million CNY | 31.52% |
| 2014 Q3 | 19.41 Million CNY | -24.31% |
| 2013 FY | 65.97 Million CNY | 4.65% |
| 2013 Q4 | 17.03 Million CNY | 5.79% |
| 2013 Q1 | 13.58 Million CNY | -17.91% |
| 2013 Q2 | 19.15 Million CNY | 41.02% |
| 2013 Q3 | 16.1 Million CNY | -15.96% |
| 2012 Q3 | 16.41 Million CNY | -14.22% |
| 2012 FY | 63.03 Million CNY | 42.58% |
| 2012 Q4 | 16.54 Million CNY | 0.83% |
| 2012 Q2 | 19.13 Million CNY | 74.87% |
| 2012 Q1 | 10.94 Million CNY | -8.96% |
| 2011 Q3 | 12.61 Million CNY | 14.91% |
| 2011 Q2 | 10.97 Million CNY | 27.47% |
| 2011 FY | 44.21 Million CNY | 3.36% |
| 2011 Q1 | 8.6 Million CNY | -0.93% |
| 2011 Q4 | 12.01 Million CNY | -4.7% |
| 2010 Q1 | 10.01 Million CNY | 22.99% |
| 2010 Q2 | 12.58 Million CNY | 25.63% |
| 2010 Q3 | 11.48 Million CNY | -8.76% |
| 2010 FY | 42.77 Million CNY | 22.69% |
| 2010 Q4 | 8.68 Million CNY | -24.32% |
| 2009 Q4 | 8.14 Million CNY | -10.39% |
| 2009 Q2 | 11.14 Million CNY | 90.33% |
| 2009 Q1 | 5.85 Million CNY | -3.05% |
| 2009 FY | 34.86 Million CNY | 33.81% |
| 2009 Q3 | 9.08 Million CNY | -18.45% |
| 2008 Q3 | 6.01 Million CNY | 0.0% |
| 2008 Q4 | 6.04 Million CNY | 0.38% |
| 2008 FY | 26.05 Million CNY | -5.84% |
| 2007 FY | 27.66 Million CNY | 125.1% |
| 2006 FY | 12.29 Million CNY | 34.48% |
| 2005 FY | 9.14 Million CNY | 0.0% |